Innate-like T-cells: a New Weapon in Cancer Immunotherapy?
New research has found a novel population of T-cells that may be more successful than current immunotherapy treatments at targeting cancer cells. James O’Brien discusses.
Continue reading
Can we control the power of the human genome?
Max Cowan explores the possibilities created by human genome sequencing and the considerations that need to be put in place for its widespread and commercial use.
The Social Machines
Despite our ever more connected world, loneliness is increasing. Jake Burton discusses how robots may be able to tackle this problem.
Will 2022 bring a ‘Male Pill’ and why haven’t we got one already?
Trials of a male contraceptive pill have been successful at preventing pregnancy in mouse models. Isabella Kwiecinski discusses how this form of non-hormonal contraceptive works and the safety concerns that need to be addressed before its clinical use.
Should we keep looking for a cure to aging?
Megan Lee explores the approaches being taken to stop aging in its tracks and the ethical issues these studies produce.
Can we leave plastic in the past?
Isabelle Goddard discusses the harmful effects of microplastics in our oceans and even in below the surface of the Earth, as well as what needs to be done to limit their future damage to the environment.
Why diversity matters: an interview with Dr Alex Ramadan
Georgia Shave speaks with Dr Alex Ramadan, a postdoctoral research scientist at the University of Oxford Physics department about the impact of including marginalised people in Physics.
Calling all artists 📣 We’re recruiting!
The Oxford Scientist is once again looking for a passionate team of creative individuals to contribute towards the artwork and illustrations in our next issue!
How close are we to fusion power?
By Molly Hammond This article was originally published in The Oxford Scientist Michaelmas Term 2021 edition, Change. Nuclear fusion is supposedly ‘always 30 years away’. It was however first theorised about a hundred years ago. What has changed in a century of research—and are we now, really, only 30 years away? In 1920, Arthur Eddington…
Vaccine drink entering trials in Oxford
By Karen Heathcote We’ve seen and heard plenty about vaccines over the last couple of years, with news outlets all over the world proudly showing images of people receiving their COVID-19 vaccination jabs. However, a new vaccine that is about to enter its next phase of trials in Oxford won’t be administered as an injection…